EP Patent

EP2437732A4 — ASSOCIATION BETWEEN AGONISTS OF DOPAMINE AND INSULIN SECRETAGOGUES OF PHASE 1 FOR THE TREATMENT OF METABOLIC DISORDERS

Assigned to Veroscience LLC · Expires 2012-10-31 · 14y expired

What this patent protects

Patent listed against bromocriptine-mesylate.

Drugs covered by this patent

bromocriptine-mesylate (BROMOCRIPTINE MESYLATE)

Patent Metadata

Patent number: EP2437732A4
Jurisdiction: EP
Classification: —
Expires: 2012-10-31
Drug substance claim: No
Drug product claim: No
Assignee: Veroscience LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.